Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.22
HRT's Cash to Debt is ranked higher than
50% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. HRT: 0.22 )
HRT' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.22

Equity to Asset 0.46
HRT's Equity to Asset is ranked higher than
56% of the 447 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. HRT: 0.46 )
HRT' s 10-Year Equity to Asset Range
Min: 0.39   Max: 0.96
Current: 0.46

0.39
0.96
F-Score: 7
Z-Score: 3.25
M-Score: -2.60
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 3.12
HRT's Operating margin (%) is ranked higher than
70% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. HRT: 3.12 )
HRT' s 10-Year Operating margin (%) Range
Min: -15.6   Max: 21.71
Current: 3.12

-15.6
21.71
Net-margin (%) 2.25
HRT's Net-margin (%) is ranked higher than
70% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. HRT: 2.25 )
HRT' s 10-Year Net-margin (%) Range
Min: -29.73   Max: 16.4
Current: 2.25

-29.73
16.4
ROE (%) 8.27
HRT's ROE (%) is ranked higher than
79% of the 445 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. HRT: 8.27 )
HRT' s 10-Year ROE (%) Range
Min: -48.14   Max: 16.68
Current: 8.27

-48.14
16.68
ROA (%) 3.45
HRT's ROA (%) is ranked higher than
75% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. HRT: 3.45 )
HRT' s 10-Year ROA (%) Range
Min: -33.69   Max: 15.41
Current: 3.45

-33.69
15.41
ROC (Joel Greenblatt) (%) 7.44
HRT's ROC (Joel Greenblatt) (%) is ranked higher than
73% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. HRT: 7.44 )
HRT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -31.89   Max: 59.15
Current: 7.44

-31.89
59.15
Revenue Growth (3Y)(%) -2.10
HRT's Revenue Growth (3Y)(%) is ranked higher than
63% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. HRT: -2.10 )
HRT' s 10-Year Revenue Growth (3Y)(%) Range
Min: -25.3   Max: 34.6
Current: -2.1

-25.3
34.6
EBITDA Growth (3Y)(%) -35.30
HRT's EBITDA Growth (3Y)(%) is ranked higher than
57% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. HRT: -35.30 )
HRT' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -35.3   Max: 39.9
Current: -35.3

-35.3
39.9
» HRT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

HRT Guru Trades in Q4 2013

Jim Simons 56,900 sh (+1.43%)
» More
Q1 2014

HRT Guru Trades in Q1 2014

Jim Simons 59,600 sh (+4.75%)
» More
Q2 2014

HRT Guru Trades in Q2 2014

Jim Simons 65,900 sh (+10.57%)
» More
Q3 2014

HRT Guru Trades in Q3 2014

Jim Simons 74,300 sh (+12.75%)
» More
» Details

Insider Trades

Latest Guru Trades with HRT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 38.20
HRT's P/E(ttm) is ranked higher than
80% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 85.90 vs. HRT: 38.20 )
HRT' s 10-Year P/E(ttm) Range
Min: 9.74   Max: 89.08
Current: 38.2

9.74
89.08
P/B 3.00
HRT's P/B is ranked higher than
76% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.88 vs. HRT: 3.00 )
HRT' s 10-Year P/B Range
Min: 0.26   Max: 12.47
Current: 3

0.26
12.47
P/S 0.90
HRT's P/S is ranked higher than
91% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. HRT: 0.90 )
HRT' s 10-Year P/S Range
Min: 0.2   Max: 14.62
Current: 0.9

0.2
14.62
EV-to-EBIT 32.42
HRT's EV-to-EBIT is ranked higher than
78% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 64.69 vs. HRT: 32.42 )
HRT' s 10-Year EV-to-EBIT Range
Min: -181.6   Max: 554.5
Current: 32.42

-181.6
554.5
Current Ratio 1.20
HRT's Current Ratio is ranked lower than
51% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. HRT: 1.20 )
HRT' s 10-Year Current Ratio Range
Min: 1.04   Max: 10.41
Current: 1.2

1.04
10.41
Quick Ratio 0.72
HRT's Quick Ratio is ranked lower than
52% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. HRT: 0.72 )
HRT' s 10-Year Quick Ratio Range
Min: 0.63   Max: 8.09
Current: 0.72

0.63
8.09

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.00
HRT's Price/Tangible Book is ranked higher than
83% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 6.71 vs. HRT: 3.00 )
HRT' s 10-Year Price/Tangible Book Range
Min: 0.38   Max: 10.73
Current: 3

0.38
10.73
Price/Median PS Value 1.20
HRT's Price/Median PS Value is ranked higher than
70% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. HRT: 1.20 )
HRT' s 10-Year Price/Median PS Value Range
Min: 0.33   Max: 14.97
Current: 1.2

0.33
14.97
Price/Graham Number 2.30
HRT's Price/Graham Number is ranked higher than
86% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. HRT: 2.30 )
HRT' s 10-Year Price/Graham Number Range
Min: 0.5   Max: 6.98
Current: 2.3

0.5
6.98
Earnings Yield (Greenblatt) 3.10
HRT's Earnings Yield (Greenblatt) is ranked higher than
77% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. HRT: 3.10 )
HRT' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 25.1
Current: 3.1

0.2
25.1
Forward Rate of Return (Yacktman) -15.40
HRT's Forward Rate of Return (Yacktman) is ranked higher than
60% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. HRT: -15.40 )
HRT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -22.8   Max: 40.7
Current: -15.4

-22.8
40.7

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Arrhythmia Research Technology was incorporated under the laws of the State of Louisiana in 1981 and reincorporated under the laws of the State of Delaware in 1987. It completed an initial public offering in 1988. The Company through its wholly-owned subsidiary is a manufacturer specializing in plastic molding, precision metal and plastics machining and precious metal coating. It is also engaged in the development and licensing of signal averaged electrocardiography (SAECG) software, through its Predictor brand. The Company's technologies used in analyzing high resolution heart signals. Its Predictor software is used in research and clinical environments to diagnose the risk of certain heart arrhythmias. The Company invests in research and development, product support and sales efforts. The Company sells its services to its customers to provide product life cycle support to their product manufacturing needs. It provides complex value added US based manufacturing capabilities in injection molding, machining and plating/coating, mold making, maintenance and repair. The Company's operations are subject to government regulations which establish compliance standards and result in costs to comply in order to participate in certain markets.
» More Articles for HRT

Headlines

Articles On GuruFocus.com
Harte Gold Discovers Hemlo Style Sericite Schist Shear Zone Along Contact Zone Nov 12 2014 
Harte Gold Reports More High Grade Results at Wolf Zone, 17.8g/t Gold Over 3.1 Meters Extends Wolf Z Oct 15 2014 
Longleaf Partners Believe HRT Could Be Their Most Exciting Investment Ever Jun 08 2011 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Nov 10 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Aug 16 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) May 04 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Oct 30 2009 
Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Sep 17 2009 
Weekly CFO Buys Highlight: Arrhythmia Research Technology, Ultra Clean Holdings, Pixelworks, Hospira Aug 16 2009 
Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Aug 12 2009 

More From Other Websites
Arrhythmia Research Tech (HRT) Upgraded From Sell to Hold Dec 04 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials Nov 21 2014
10-Q for Arrhythmia Research Technology, Inc. Nov 14 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Nov 12 2014
Arrhythmia Research Technology, Inc. Achieved 27.9% Revenue Growth and $0.05 Earnings Per Share for... Nov 12 2014
Micron Products, Inc. Appoints Albert McGrath as Vice President of Operations Oct 30 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Aug 08 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive... Jul 01 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of... May 27 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report May 09 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials Mar 27 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Mar 21 2014
Arrhythmia Research Technology, Inc. Announces Fourth Quarter and 2013 Year End Results Mar 21 2014
Needing Smarter, More Cost-Effective Production, Medical OEMs Turn to Contract Manufacturing Mar 11 2014
Arrhythmia Research Technology, Inc. Announces Supply Agreement With Blue Belt Technologies, Inc. Feb 19 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure Feb 14 2014
Arrhythmia Research Technology, Inc. Announces Date of Annual Meeting of Shareholders Feb 14 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal... Jan 14 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of... Jan 10 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive... Dec 23 2013

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK